Melyssa Grieve

• Dr
• The University of Queensland
• @melyssa-grieve-2286861b2

Melyssa is a radiochemist with a research focus on developing chelators for targeted alpha therapy and understanding the biological mechanisms that result from treatment. Her research has primarily been focussed on developing and optimising the radiochemistry of both established and novel chelators with both diagnostic and therapeutic radionuclides. Through this work she has performed the initial design and synthesis of new chelators, investigated the properties of the non-radioactive metal complexes and developed the radiochemistry for the corresponding radiolabelled compounds. Melyssa has experience with a range of radionuclides including the PET radionuclides ⁶⁸Ga, ⁶⁴Cu, ⁸⁹Zr and ¹³³La, SPECT radionuclides ^99mTc, ¹¹¹In, ²⁰³Pb, ¹³¹Ba and therapeutic radionuclides ¹⁷⁷Lu, ²¹²Pb, ²¹²Bi, ¹⁶¹Tb, ²²⁴Ra and ²²⁵Ac.

View All People